Sonoma Pharmaceuticals Inc (SNOA)
0.1604
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
0.162
0.00 (0.00%)
Pre-Market: 20:00
Sonoma Pharmaceuticals Total Liabilities (Quarterly): 7.926M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.926M |
| September 30, 2023 | 7.96M |
| June 30, 2023 | 8.651M |
| March 31, 2023 | 8.254M |
| December 31, 2022 | 8.369M |
| September 30, 2022 | 7.941M |
| June 30, 2022 | 9.199M |
| March 31, 2022 | 10.15M |
| December 31, 2021 | 8.178M |
| September 30, 2021 | 8.368M |
| June 30, 2021 | 9.50M |
| March 31, 2021 | 9.624M |
| December 31, 2020 | 5.915M |
| September 30, 2020 | 6.583M |
| June 30, 2020 | 7.242M |
| March 31, 2020 | 8.937M |
| December 31, 2019 | 5.287M |
| September 30, 2019 | 5.874M |
| June 30, 2019 | 5.414M |
| March 31, 2019 | 3.959M |
| December 31, 2018 | 3.705M |
| September 30, 2018 | 3.563M |
| June 30, 2018 | 4.004M |
| March 31, 2018 | 3.88M |
| December 31, 2017 | 4.099M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.993M |
| June 30, 2017 | 3.815M |
| March 31, 2017 | 4.028M |
| December 31, 2016 | 4.644M |
| September 30, 2016 | 3.202M |
| June 30, 2016 | 3.57M |
| March 31, 2016 | 3.663M |
| December 31, 2015 | 2.98M |
| September 30, 2015 | 2.836M |
| June 30, 2015 | 3.069M |
| March 31, 2015 | 2.994M |
| December 31, 2014 | 4.006M |
| September 30, 2014 | 5.024M |
| June 30, 2014 | 6.475M |
| March 31, 2014 | 8.728M |
| December 31, 2013 | 6.446M |
| September 30, 2013 | 7.332M |
| June 30, 2013 | 7.964M |
| March 31, 2013 | 8.484M |
| December 31, 2012 | 8.702M |
| September 30, 2012 | 13.89M |
| June 30, 2012 | 9.351M |
| March 31, 2012 | 8.706M |
| December 31, 2011 | 8.818M |
| September 30, 2011 | 7.899M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.287M
Minimum
Dec 2019
10.15M
Maximum
Mar 2022
7.862M
Average
8.178M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.62M |
| Shareholders Equity (Quarterly) | 6.692M |
| Debt to Equity Ratio | 0.0066 |
| Current Ratio | 4.067 |
| Net Debt Paydown Yield | 1.62% |